Trials / Completed
CompletedNCT00013156
Cost-Effectiveness of Lung Volume Reduction Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- Male
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS.
Detailed description
Background: Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS. Objectives: Evaluate cost-effectiveness of LVRS compared to current therapy for COPD. Methods: This is a case control study in which veterans undergoing LVRS at VA Puget Sound Health Care System (VAPSHCS) are compared to patients with a similar severity of disease at Boise VAMC who are not undergoing LVRS. Changes in health related quality of life are being evaluated using three instruments: the SF-36, the St. George�s Respiratory Questionnaire, and the Quality of Well-Being Scale, the latter to calculate utility associated with different health states. Costs will be determined using utilization data on outpatient visits, medications, oxygen use, inpatient days, radiology tests, laboratory tests, and emergency room visits are being collected for the twelve months before and after surgery. Costs will be calculated according to VA and community standards. Status: Complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Effectiveness of Lung Reduction Therapy |
Timeline
- Completion
- 2000-03-01
- First posted
- 2001-03-16
- Last updated
- 2015-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00013156. Inclusion in this directory is not an endorsement.